Cardiovascular Research - Immunity and Atherosclerosis
131 – 140 of 559
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Cartilage Oligomeric Matrix Protein Associates With a Vulnerable Plaque Phenotype in Human Atherosclerotic Plaques
(
- Contribution to journal › Article
-
Mark
Sarcopenia is common in adults with complex congenital heart disease
(
- Contribution to journal › Article
-
Mark
Inhibition of pro-inflammatory myeloid cell responses by short-term S100A9 blockade improves cardiac function after myocardial infarction
(
- Contribution to journal › Article
-
Mark
Lack of Ability to Present Antigens on Major Histocompatibility Complex Class II Molecules Aggravates Atherosclerosis in ApoE-/- Mice
(
- Contribution to journal › Article
-
Mark
The effects of Cernitin® on inflammatory parameters and benign prostatic hyperplasia : An in vitro study
(
- Contribution to journal › Article
-
Mark
Biomarkers of blood cadmium and incidence of cardiovascular events in non-smokers : Results from a population-based proteomics study
(
- Contribution to journal › Article
-
Mark
Soluble TRAIL-R2 a marker of plaque cell apoptosis and cardiovascular events.
(
- Contribution to journal › Article
-
Mark
The soluble receptor for advanced glycation end-products (sRAGE) has a dual phase-dependent association with residual cardiovascular risk after an acute coronary event.
(
- Contribution to journal › Article
-
Mark
Cardiovascular organ damage in type 2 diabetes mellitus : The role of lipids and inflammation
(
- Contribution to journal › Article
-
Mark
High Plasma sRAGE (Soluble Receptor for Advanced Glycation End Products) Is Associated With Slower Carotid Intima-Media Thickness Progression and Lower Risk for First-Time Coronary Events and Mortality
(
- Contribution to journal › Article